Medtech InsightOlympus Corporation is over halfway through its five-year corporate strategy, set in 2019, by the end of which it will be growing at rate of 5-6% annually and making an operating margin of over 20%.
In VivoOlympus Corporation is over halfway through its five-year corporate strategy, set in 2019, by the end of which it will be growing at rate of 5-6% annually and making an operating margin of over 20%.
Medtech InsightOlympus Corporation said the acquisition of Veran Medical Technologies (VMT), a maker of computer-guided bronchoscopes and cancer biopsy systems, for up to $340m, will help it build a stronger resp